文献速递药物不良反应与药物警戒特殊人群用药

仅用药物数据识别诊断及相关禁忌症:算法应用以弥补常见记录缺口

Use of medication data alone to identify diagnoses and related contraindications: Application of algorithms to close a common documentation gap.
PubMed 文献 · Br J Clin Pharmacol · 2022-08-08

本研究基于药物使用模式开发专家规则和机器学习算法,从仅有的药物数据中识别痛风、癫痫、冠心病、充血性心力衰竭和支气管梗阻等禁忌症相关诊断。在3506份老年患者出院记录的真实匿名样本中,算法特异度为44.0-99.8%(95%CI 41.7-100.0%),敏感度为3.8-83.1%(95%CI 1.0-86.1%)。仅用药物数据可识别专家结合诊断数据确认的240个禁忌症中的123个(51.3%)。

要点

  • 仅凭药物数据可识别部分诊断相关禁忌症,但并非全部。
  • 算法性能因疾病和侧重(敏感度vs特异度)而异,特异度最高达99.8%。
  • 该方法为社区药房或临床常规数据中分析药物-疾病禁忌提供新机会。

核心结论

  • 仅用药物数据可识别部分关键诊断相关禁忌症,但部分禁忌症无法识别。

研究设计与样本

  • 基于药物使用模式开发专家规则和机器学习算法,使用3506份老年患者出院记录的匿名真实药物和诊断数据评估适用性、敏感度和特异度。

主要发现

  • 算法识别痛风、癫痫、冠心病、充血性心力衰竭和支气管梗阻的特异度为44.0-99.8%(95%CI 41.7-100.0%),敏感度为3.8-83.1%(95%CI 1.0-86.1%)。
  • 仅用药物数据识别出专家结合药物和诊断数据确认的240个禁忌症中的123个(51.3%)。

关键数值与推荐

  • 基于独家用于特定疾病的药物(如别嘌醇用于痛风、沙丁胺醇用于支气管梗阻)构建高特异性药物模式。
  • 算法性能因疾病和期望侧重(敏感度vs特异度)而异。

临床怎么用

  • 可在社区药房或临床常规数据中仅基于药物数据分析药物-疾病禁忌症。

局限性

  • 部分诊断相关禁忌症无法仅通过药物数据识别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Automated checks for medication-related problems have become a cornerstone of medication safety. In many clinical settings medication checks remain confined to drug-drug interactions because only medication data are available in an adequately coded form, leaving possible contraindicated drug-disease combinations unaccounted for. Therefore, we devised algorithms that identify frequently contraindicated diagnoses based on medication patterns related to these diagnoses. METHODS: We identified drugs that are associated with diseases constituting common contraindications based on their exclusive use for these conditions (such as allopurinol for gout or salbutamol for bronchial obstruction). Expert-based and machine learning algorithms were developed to identify diagnoses based on highly specific medication patterns. The applicability, sensitivity and specificity of the approach were assessed by using an anonymized real-life sample of medication and diagnosis data excerpts from 3506 discharge records of geriatric patients. RESULTS: Depending on the algorithm, the desired focus (i.e., sensitivity vs. specificity) and the disease, we were able to identify the diagnoses gout, epilepsy, coronary artery disease, congestive heart failure and bronchial obstruction with a specificity of 44.0-99.8% (95% CI 41.7-100.0%) and a sensitivity of 3.8-83.1% (95% CI 1.0-86.1%). Using only medication data, we were able to identify 123 (51.3%) of 240 contraindications identified by experts with access to medication data and diagnoses. CONCLUSION: This study provides a proof of principle that some key diagnosis-related contraindications can be identified based on a patient's medication data alone, while others cannot be identified. This approach offers new opportunities to analyse drug-disease contraindications in community pharmacy or clinical routine data.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Andrikyan W, Then MI, Gaßmann KG, et al. Use of medication data alone to identify diagnoses and related contraindications: Application of algorithms to close a common documentation gap. Br J Clin Pharmacol. 2022. PMID: 35877931. doi:10.1111/bcp.15469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。